With decades of experience ranging from design, development, regulatory, manufacturing and commercialization of medical devices, SweetBio’s diverse and passionate executive team is uniquely equipped to propel SweetBio to the next phase and beyond.
Kayla RODRIGUEZ Graff, m.b.a. - Co-founder, CEO
Kayla earned her MBA in 2014 from Hult International in San Francisco, CA and New York City, NY. Her forward thinking business mindset is unique and her overall knowledge of business development, marketing, operations, organizational effectiveness, and front-end web development in Fortune 40 experience made her a fit for the CEO role. She is responsible for operational efficiency and marketing. Email and connect with Kayla.
ISAAC RODRIGUEZ, Ph.D. - co-founder, CSO
Dr. Rodriguez’s dissertation was dedicated to this technology and he has the science expertise to lead efforts towards product development. With years of biomedical experience along with leadership experience with statewide community development programs, Isaac is the SweetBio Chief Science Officer responsible for the lab and clinical research, publication, regulatory and product development segments of the business. Email and connect with Isaac.
Axel Strombergsson, M.Sc. - COO
Axel has a masters in mechanical engineering and has spent more than a decade in bringing innovative medical devices to the market. His expertise lies within product realization ranging from early prototyping through development, manufacturing, regulatory approvals and into the market. His deep, and extremely broad medical device knowledge makes him a perfect fit for the SweetBio COO role, where Axel is taking the responsibility for the product operations side of our business. Email and connect with Axel.
Martin klazmer - vice president, commercialization
Proven medical device expert with 10+ years of experience in Marketing, Sales, and Commercialization in both startup and large device companies. Lead teams responsible for launching 35+ products with revenues up to $100M. Guided multiple companies through growth phases, which has included an IPO and two acquisitions. Email and connect with Martin.